Recon: Pfizer’s maternal RSV vaccine headed to FDA after hitting study endpoints; J&J to acquire heart pump maker Abiomed for $16.6B
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy